Filed: 2/13/2026ACC: 0001420506-26-000422
📋 What this filing means
PROSIGHT MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 38 equity positions with a total reported market value of $483.93M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
38
Positions
$483.93M
Total AUM (reported)
35.53M
Total Shares
Allocation by class
COM$293.39M60.6%
SHS$63.58M13.1%
SPON ADR$35.12M7.3%
COM NEW$31.64M6.5%
CL A COM$20.12M4.2%
COMMON STOCK$17.54M3.6%
COM CL A$9.52M2.0%
Portfolio Concentration
Top 3$111.56M23.1%
4–10$165.36M34.2%
11–25$172.96M35.7%
Rest$34.04M7.0%
Top 3 weight
23.1%
Top 10 weight
57.2%
Voting Authority Distribution
Total shares with voting rights: 35.53M
Sole
Full voting authority
35.53M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole38
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings38
Rows:
PROCEPT BIOROBOTICS CORP
SOLEShares1.38M
TypeSH
Market value$43.41M
8.97%
Sole
1.38M
Shared
0.00
None
0.00
GALAPAGOS NV
SOLEShares1.07M
TypeSH
Market value$35.12M
7.26%
Sole
1.07M
Shared
0.00
None
0.00
JANUX THERAPEUTICS INC
SOLEShares2.39M
TypeSH
Market value$33.02M
6.82%
Sole
2.39M
Shared
0.00
None
0.00
ADC THERAPEUTICS SA
SOLEShares8.48M
TypeSH
Market value$29.93M
6.18%
Sole
8.48M
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares2.53M
TypeSH
Market value$26.28M
5.43%
Sole
2.53M
Shared
0.00
None
0.00
MEIRAGTX HLDGS PLC
SOLEShares3.21M
TypeSH
Market value$25.52M
5.27%
Sole
3.21M
Shared
0.00
None
0.00
NEKTAR THERAPEUTICS
SOLEShares554.63K
TypeSH
Market value$23.45M
4.85%
Sole
554.63K
Shared
0.00
None
0.00
VEEVA SYS INC
SOLEShares90.13K
TypeSH
Market value$20.12M
4.16%
Sole
90.13K
Shared
0.00
None
0.00
ICON PLC
SOLEShares110K
TypeSH
Market value$20.04M
4.14%
Sole
110K
Shared
0.00
None
0.00
BOSTON SCIENTIFIC CORP
SOLEShares210K
TypeSH
Market value$20.02M
4.14%
Sole
210K
Shared
0.00
None
0.00
CONCENTRA GROUP HOLDINGS PAR
SOLEShares891.03K
TypeSH
Market value$17.54M
3.62%
Sole
891.03K
Shared
0.00
None
0.00
PHREESIA INC
SOLEShares977.15K
TypeSH
Market value$16.53M
3.42%
Sole
977.15K
Shared
0.00
None
0.00
AMICUS THERAPEUTICS INC
SOLEShares1.15M
TypeSH
Market value$16.38M
3.38%
Sole
1.15M
Shared
0.00
None
0.00
SELECT MED HLDGS CORP
SOLEShares1.04M
TypeSH
Market value$15.37M
3.18%
Sole
1.04M
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares665K
TypeSH
Market value$13.97M
2.89%
Sole
665K
Shared
0.00
None
0.00
ZYMEWORKS INC
SOLEShares530.39K
TypeSH
Market value$13.97M
2.89%
Sole
530.39K
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares627.16K
TypeSH
Market value$13.61M
2.81%
Sole
627.16K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares262.90K
TypeSH
Market value$12.24M
2.53%
Sole
262.90K
Shared
0.00
None
0.00
AVANTOR INC
SOLEShares898.50K
TypeSH
Market value$10.30M
2.13%
Sole
898.50K
Shared
0.00
None
0.00
SHATTUCK LABS INC
SOLEShares2.38M
TypeSH
Market value$8.69M
1.80%
Sole
2.38M
Shared
0.00
None
0.00
LABCORP HOLDINGS INC
SOLEShares34.53K
TypeSH
Market value$8.66M
1.79%
Sole
34.53K
Shared
0.00
None
0.00
GENEDX HOLDINGS CORP
SOLEShares55K
TypeSH
Market value$7.15M
1.48%
Sole
55K
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
SOLEShares17.11K
TypeSH
Market value$6.80M
1.41%
Sole
17.11K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares243.40K
TypeSH
Market value$6.19M
1.28%
Sole
243.40K
Shared
0.00
None
0.00
CORBUS PHARMACEUTICALS HLDGS
SOLEShares683.87K
TypeSH
Market value$5.57M
1.15%
Sole
683.87K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
PROCEPT BIOROBOTICS CORPSOLE | COM | 1.38M | SH | $43.41M 8.97% | 1.38M | 0.00 | 0.00 |
GALAPAGOS NVSOLE | SPON ADR | 1.07M | SH | $35.12M 7.26% | 1.07M | 0.00 | 0.00 |
JANUX THERAPEUTICS INCSOLE | COM | 2.39M | SH | $33.02M 6.82% | 2.39M | 0.00 | 0.00 |
ADC THERAPEUTICS SASOLE | SHS | 8.48M | SH | $29.93M 6.18% | 8.48M | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COM | 2.53M | SH | $26.28M 5.43% | 2.53M | 0.00 | 0.00 |
MEIRAGTX HLDGS PLCSOLE | COM | 3.21M | SH | $25.52M 5.27% | 3.21M | 0.00 | 0.00 |
NEKTAR THERAPEUTICSSOLE | COM NEW | 554.63K | SH | $23.45M 4.85% | 554.63K | 0.00 | 0.00 |
VEEVA SYS INCSOLE | CL A COM | 90.13K | SH | $20.12M 4.16% | 90.13K | 0.00 | 0.00 |
ICON PLCSOLE | SHS | 110K | SH | $20.04M 4.14% | 110K | 0.00 | 0.00 |
BOSTON SCIENTIFIC CORPSOLE | COM | 210K | SH | $20.02M 4.14% | 210K | 0.00 | 0.00 |
CONCENTRA GROUP HOLDINGS PARSOLE | COMMON STOCK | 891.03K | SH | $17.54M 3.62% | 891.03K | 0.00 | 0.00 |
PHREESIA INCSOLE | COM | 977.15K | SH | $16.53M 3.42% | 977.15K | 0.00 | 0.00 |
AMICUS THERAPEUTICS INCSOLE | COM | 1.15M | SH | $16.38M 3.38% | 1.15M | 0.00 | 0.00 |
SELECT MED HLDGS CORPSOLE | COM | 1.04M | SH | $15.37M 3.18% | 1.04M | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 665K | SH | $13.97M 2.89% | 665K | 0.00 | 0.00 |
ZYMEWORKS INCSOLE | COM | 530.39K | SH | $13.97M 2.89% | 530.39K | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHS | 627.16K | SH | $13.61M 2.81% | 627.16K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 262.90K | SH | $12.24M 2.53% | 262.90K | 0.00 | 0.00 |
AVANTOR INCSOLE | COM | 898.50K | SH | $10.30M 2.13% | 898.50K | 0.00 | 0.00 |
SHATTUCK LABS INCSOLE | COM | 2.38M | SH | $8.69M 1.80% | 2.38M | 0.00 | 0.00 |
LABCORP HOLDINGS INCSOLE | COM SHS | 34.53K | SH | $8.66M 1.79% | 34.53K | 0.00 | 0.00 |
GENEDX HOLDINGS CORPSOLE | COM CL A | 55K | SH | $7.15M 1.48% | 55K | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 17.11K | SH | $6.80M 1.41% | 17.11K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 243.40K | SH | $6.19M 1.28% | 243.40K | 0.00 | 0.00 |
CORBUS PHARMACEUTICALS HLDGSSOLE | COM NEW | 683.87K | SH | $5.57M 1.15% | 683.87K | 0.00 | 0.00 |
Page 1 of 2